Siegmund Karasch
Director/Miembro de la Junta en DEUTSCHE BIOTECH INNOVATIV AG .
Perfil
Siegmund Karasch is the founder of AdrenoMed AG.
He is currently a Member-Supervisory Board at Deutsche Biotech Innovativ AG since 2018.
Previously, he worked as Chief Executive & Operating Officer at InVivo BioTech Services GmbH.
He completed his undergraduate degree from Hochschule für Technik und Wirtschaft Berlin in 1993.
Cargos activos de Siegmund Karasch
Empresas | Cargo | Inicio |
---|---|---|
DEUTSCHE BIOTECH INNOVATIV AG | Director/Miembro de la Junta | 05/07/2018 |
Antiguos cargos conocidos de Siegmund Karasch.
Empresas | Cargo | Fin |
---|---|---|
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Fundador | 01/01/2014 |
InVivo BioTech Services GmbH
InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology InVivo BioTech Services GmbH engages in contract manufacturing organization dedicated to the development and production of monoclonal antibodies and expression of recombinant proteins. The company was founded by Andreas Bergmann in 1998 and is headquartered in Hennigsdorf, Germany. | Director Ejecutivo | - |
Formación de Siegmund Karasch.
Hochschule für Technik und Wirtschaft Berlin | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
DEUTSCHE BIOTECH INNOVATIV AG | Finance |
Empresas privadas | 2 |
---|---|
InVivo BioTech Services GmbH
InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology InVivo BioTech Services GmbH engages in contract manufacturing organization dedicated to the development and production of monoclonal antibodies and expression of recombinant proteins. The company was founded by Andreas Bergmann in 1998 and is headquartered in Hennigsdorf, Germany. | Health Technology |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Siegmund Karasch